Reed Elsevier, the global professional information company, has today issued a statement relating to the first nine months trading performance and reaffirming the full year outlook for 2013. First nine months underlying revenue growth was +3% (also +3% excluding biennial exhibition cycling).
The evolution of our portfolio has continued. Since the interim results we have announced a number of acquisitions of small content and data assets, including Enclarity and Mapflow in Risk Solutions. We have completed additional disposals including RBI Italy and a number of other small assets across business areas.
Reed Elsevier’s financial position remains strong with good cash generation. We have completed £550m of share buy backs so far this year, and intend to complete the remainder of the previously announced £600m total by the end of the year.

Full year outlook: The outlook remains unchanged, with underlying revenue, operating profit, and earnings growth on track for the full year.
In a mixed macro economic environment, positive underlying growth trends were maintained across all major business areas in the first nine months of 2013.

Scientific, Technical & Medical Underlying revenue growth +2%.
Article submissions and usage grew strongly. Primary research subscriptions, scientific databases & tools, and clinical solutions all grew well. Sales of print books to individuals and pharma promotion revenues continued to decline.
Full year outlook: We remain on track to deliver modest underlying revenue growth for the full year.

Risk Solutions & Business Information Risk Solutions and Business Information achieved a combined +6% underlying revenue growth.
Risk Solutions Underlying revenue growth +8%.
All business segments continued to achieve strong growth in the first nine months, with good growth in both established and recently developed services in insurance, and strong demand for fraud detection services in government markets. Good growth in business services was maintained, despite some slowdown in the US mortgage refinancing market.
Full year outlook: Some uncertainty remains in financial and government markets, but overall we expect good growth to continue for the remainder of the year.

Business Information Underlying revenue growth +3%.
Major Data Services continued to achieve strong growth, primarily driven by Accuity and ICIS. Leading Brands remained stable despite weak print advertising markets.
Full year outlook: We expect the growth trends achieved in the first nine months to continue for the remainder of 2013.
Legal Underlying revenue growth +1%.
Customer markets remained subdued in the US and Europe, with online growth largely offset by print declines. Good progress has been made on the continued roll out of new platforms and applications, and on the initial decommissioning of old infrastructure.

Full year outlook: We expect our customer markets to remain subdued, limiting the scope for revenue growth.
Exhibitions Underlying revenue growth including biennial cycling +5% (+10% excluding cycling).
The strong underlying growth rates for the first nine months benefited from around three percentage points of positive timing and mix effects which are expected to unwind in the full year. Growth continued to be modest in Europe, and strong in the US, Japan, Brazil, China, and other markets.
Full year outlook: The outlook for growth remains limited in Europe and good in the US and Japan. In other markets the outlook is strong, albeit slightly below recent high levels.
-ENDS-

tijd 14.09
Reed Elsevier EUR 15,34 +15ct vol. 1,2 miljoen.

tijd 13.48 d.d. 8/11/2013
Reed Elsevier EUR 15,24
Onze favoriet van dit jaar en latere,
Kijk eens wat dit aandeel gedaan heeft vanaf november 2012, toen EUR 10 en een klein beetje nu EUR 15 en een kleine beetje, ook nog eens ruim 40ct dividend, dat is wel ruim 50% in 1 jaar tijd. En er zit nog meer in het vat is onze taxatie.
hier een dividend overzicht
Reed Elsevier NV 2006 2007 2008 2009 2010 2011 2012 2013
Interim div. (€) 0.102 0.114 0.114 0.107 0.109 0.110 0.130 0.132
Final dividend (€) 0.304 0.311 0.290 0.293 0.303 0.326 0.337
Total dividend (€) 0.406 0.425 0.404 0.400 0.412 0.436 0.467
plus een mooie stijging van de prijs van het aandeel en weinig zorgen.
Wat wilt U nog meer?